DAPK2 and non-small cell lung carcinoma: The results show that smoking cigarettes alters DAPK2, which may be a therapeutic target for patients with NSCLC caused by smoking and provide new information on the mechanisms behind the development of NSCLC (Jin et al., 2021[94]).